Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1993 3
1995 6
1996 12
1997 4
1998 3
1999 9
2000 12
2001 10
2002 12
2003 5
2004 1
2005 4
2006 2
2007 8
2008 6
2009 11
2010 10
2011 16
2012 20
2013 15
2014 22
2015 31
2016 18
2017 25
2018 19
2019 13
2020 24
2021 13
2022 9
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

325 results

Results by year

Filters applied: . Clear all
Page 1
Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.
Schito M, Migliori GB, Fletcher HA, McNerney R, Centis R, D'Ambrosio L, Bates M, Kibiki G, Kapata N, Corrah T, Bomanji J, Vilaplana C, Johnson D, Mwaba P, Maeurer M, Zumla A. Schito M, et al. Among authors: maeurer m. Clin Infect Dis. 2015 Oct 15;61Suppl 3(Suppl 3):S102-18. doi: 10.1093/cid/civ609. Clin Infect Dis. 2015. PMID: 26409271 Free PMC article.
Single-cell landscape of immunological responses in patients with COVID-19.
Zhang JY, Wang XM, Xing X, Xu Z, Zhang C, Song JW, Fan X, Xia P, Fu JL, Wang SY, Xu RN, Dai XP, Shi L, Huang L, Jiang TJ, Shi M, Zhang Y, Zumla A, Maeurer M, Bai F, Wang FS. Zhang JY, et al. Among authors: maeurer m. Nat Immunol. 2020 Sep;21(9):1107-1118. doi: 10.1038/s41590-020-0762-x. Epub 2020 Aug 12. Nat Immunol. 2020. PMID: 32788748
Host-directed therapies for COVID-19.
Maeurer M, Ramalho R, Wang FS, Zumla A. Maeurer M, et al. Curr Opin Pulm Med. 2021 May 1;27(3):205-209. doi: 10.1097/MCP.0000000000000769. Curr Opin Pulm Med. 2021. PMID: 33629969 Review.
COVID-19 and tuberculosis-threats and opportunities.
Zumla A, Marais BJ, McHugh TD, Maeurer M, Zumla A, Kapata N, Ntoumi F, Chanda-Kapata P, Mfinanga S, Centis R, Cirillo DM, Petersen E, Hui DS, Ippolito G, Leung CC, Migliori GB, Tiberi S. Zumla A, et al. Among authors: maeurer m. Int J Tuberc Lung Dis. 2020 Aug 1;24(8):757-760. doi: 10.5588/ijtld.20.0387. Int J Tuberc Lung Dis. 2020. PMID: 32912377 No abstract available.
Immune responses during COVID-19 infection.
Melenotte C, Silvin A, Goubet AG, Lahmar I, Dubuisson A, Zumla A, Raoult D, Merad M, Gachot B, Hénon C, Solary E, Fontenay M, André F, Maeurer M, Ippolito G, Piacentini M, Wang FS, Ginhoux F, Marabelle A, Kroemer G, Derosa L, Zitvogel L. Melenotte C, et al. Among authors: maeurer m. Oncoimmunology. 2020 Aug 25;9(1):1807836. doi: 10.1080/2162402X.2020.1807836. Oncoimmunology. 2020. PMID: 32939324 Free PMC article. Review.
Targeting innate immunity for tuberculosis vaccination.
Khader SA, Divangahi M, Hanekom W, Hill PC, Maeurer M, Makar KW, Mayer-Barber KD, Mhlanga MM, Nemes E, Schlesinger LS, van Crevel R, Vankayalapati R(, Xavier RJ, Netea MG; Bill and Melinda Gates Foundation Collaboration for TB Vaccine Discovery Innate Immunity Working Group18. Khader SA, et al. Among authors: maeurer m. J Clin Invest. 2019 Sep 3;129(9):3482-3491. doi: 10.1172/JCI128877. J Clin Invest. 2019. PMID: 31478909 Free PMC article. Review.
325 results